Skip to main content
SpringerLink
Log in

Ertapenem as effective as other antibacterials in treating intra-abdominal, skin, urinary, respiratory tract and acute pelvic infections

  • Drugs and Profile Report
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Fig. 1
Table II

Notes

  1. The use of trade names is for product identification purposes only and does not imply endorsement.

References

  1. Curran MP, Simpson D, Perry CM. Ertapenem: a review of its use in the management of bacterial infections. Drugs 2003: 63(17) 1855–78

    Article  PubMed  CAS  Google Scholar 

  2. Merck&Co. Inc. Invanz (ertapenem for injection) prescribing information. Whitehouse Station (NJ): Merck & Co. Inc., 2001

  3. Solomkin JS, Yellin AE, Rotstein OD, et al. Ertapenem versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections: results of a double-blind, randomized comparative phase III trial. Ann Surg 2003 Feb; 237(2): 235–45

    PubMed  Google Scholar 

  4. Yellin AE, Hassett JM, Fernandez A, et al. Ertapenem monotherapy versus combination therapy with ceftriaxone plus metronidazole for treatment of complicated intra-abdominal infections in adults. Int J Antimicrob Agents 2002 Sep; 20(3): 165–73

    Article  PubMed  CAS  Google Scholar 

  5. Graham DR, Lucasti C, Malafaia O, et al. Ertapenem once daily versus piperacillin-tazobactam 4 times per day for treatment of complicated skin and skin-structure infections in adults: results of a prospective, randomized, double-blind multicenter study. Clin Infect Dis 2002 Jun 1; 34(11): 1460–8

    Article  PubMed  CAS  Google Scholar 

  6. Jimenez-Cruz F, Jasovich A, Cajigas J, et al. A prospective, multicenter, randomized, double-blind study comparing ertapenem and ceftriaxone followed by appropriate oral therapy for complicated urinary tract infections in adults. Urology 2002 Jul; 60(1): 16–22

    Article  PubMed  Google Scholar 

  7. Tomera KM, Burdmann EA, Reyna OG, et al. Ertapenem versus ceftriaxone followed by appropriate oral therapy for treatment of complicated urinary tract infections in adults: results of a prospective, randomized, double-blind multicenter study. Antimicrob Agents Chemother 2002 Sep; 46(9): 2895–900

    Article  PubMed  CAS  Google Scholar 

  8. Ortiz-Ruiz G, Caballero-Lopez J, Friedland IR, et al. A study evaluating the efficacy, safety, and tolerability of ertapenem versus ceftriaxone for the treatment of community-acquired pneumonia in adults. Clin Infect Dis 2002 Apr 15; 34(8): 1076–83

    Article  PubMed  CAS  Google Scholar 

  9. Vetter N, Cambronero-Hernandez E, Rohlf J, et al. A prospective, randomized, double-blind multicenter comparison of parenteral ertapenem and ceftriaxone for the treatment of hospitalized adults with community-acquired pneumonia. Clin Ther 2002 Nov; 24(11): 1770–85

    Article  PubMed  CAS  Google Scholar 

  10. Roy S, Higareda I, Angel-Muller E, et al. Ertapenem once a day versus piperacillin-tazobactam every 6 hours for treatment of acute pelvic infections: a prospective mulitcenter, randomized double-blind study. Infect Dis Obstet Gynecol 2003; 11: 27–37

    Article  PubMed  CAS  Google Scholar 

  11. Gesser RM, McCarroll K, Teppler H, et al. Efficacy of ertapenem in the treatment of serious infections caused by Enterobacteriaceae: analysis of pooled clinical trial data. J Antimicrob Chemother 2003 Apr 14; 51: 1253–60

    Article  PubMed  CAS  Google Scholar 

  12. Tellado J, Woods GL, Gesser R, et al. Ertapenem versus piperacillin-tazobactam for treatment of mixed anaerobic complicated intra-abdominal, complicated skin and skin structure, and acute pelvic infections. Surg Infect (Larchmt) 2002; 3(4): 303–14

    Article  Google Scholar 

  13. Merck Sharp & Dohme Limited. Invanz™ summary of product characteristics. Hoddesdon (Hertfordshire): Merck Sharp & Dohme Limited, 2002

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ertapenem as effective as other antibacterials in treating intra-abdominal, skin, urinary, respiratory tract and acute pelvic infections. Drugs Ther. Perspect 20, 1–4 (2004). https://doi.org/10.2165/00042310-200420070-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-200420070-00001

Search

Navigation